Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Pye

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Current Eye Research|March 17, 2007
Assessment of corneal biomechanical properties and their variation with ageAhmed Elsheikh, Defu Wang, Michael Brown, et al.
Journal of Glaucoma|September 28, 2011
Correction factors for Goldmann TonometryAhmed Elsheikh, Pinakin Gunvant, Stephen W Jones, et al.
Biochemistry|January 30, 2002
Different affinities of glycosaminoglycan oligosaccharides for monomeric and dimeric interleukin-8: a model for chemokine regulation at inflammatory sitesBirgit Goger, Yvonne Halden, Angelika Rek, et al.
Journal of Virology|November 23, 2007
Phase I trial of a CD8+ T-cell peptide epitope-based vaccine for infectious mononucleosisSuzanne L Elliott, Andreas Suhrbier, John J Miles, et al.
Vaccine|November 8, 2003
Safety and immunogenicity of a three-component blood-stage malaria vaccine (MSP1, MSP2, RESA) against Plasmodium falciparum in Papua New Guinean childrenBlaise Genton, Fadwa Al-Yaman, Inoni Betuela, et al.
Vaccine|April 7, 2005
A human phase 1 vaccine clinical trial of the Plasmodium falciparum malaria vaccine candidate apical membrane antigen 1 in Montanide ISA720 adjuvantAllan Saul, Greg Lawrence, Anthony Allworth, et al.
The Journal of Infectious Diseases|March 29, 2002
A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New GuineaBlaise Genton, Inoni Betuela, Ingrid Felger, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Current Eye Research|March 17, 2007
Assessment of corneal biomechanical properties and their variation with ageAhmed Elsheikh, Defu Wang, Michael Brown, et al.
Journal of Glaucoma|September 28, 2011
Correction factors for Goldmann TonometryAhmed Elsheikh, Pinakin Gunvant, Stephen W Jones, et al.
Biochemistry|January 30, 2002
Different affinities of glycosaminoglycan oligosaccharides for monomeric and dimeric interleukin-8: a model for chemokine regulation at inflammatory sitesBirgit Goger, Yvonne Halden, Angelika Rek, et al.
Journal of Virology|November 23, 2007
Phase I trial of a CD8+ T-cell peptide epitope-based vaccine for infectious mononucleosisSuzanne L Elliott, Andreas Suhrbier, John J Miles, et al.
Vaccine|November 8, 2003
Safety and immunogenicity of a three-component blood-stage malaria vaccine (MSP1, MSP2, RESA) against Plasmodium falciparum in Papua New Guinean childrenBlaise Genton, Fadwa Al-Yaman, Inoni Betuela, et al.
Vaccine|April 7, 2005
A human phase 1 vaccine clinical trial of the Plasmodium falciparum malaria vaccine candidate apical membrane antigen 1 in Montanide ISA720 adjuvantAllan Saul, Greg Lawrence, Anthony Allworth, et al.
The Journal of Infectious Diseases|March 29, 2002
A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New GuineaBlaise Genton, Inoni Betuela, Ingrid Felger, et al.
Pageof 2